[PHARMA] YoY Cumulative Quarter Result on 30-Sep-2010 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
04-Nov-2010
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2010
Quarter
30-Sep-2010 [#3]
Profit Trend
QoQ- 35.69%
YoY- -14.73%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Cumulative Result
30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 CAGR
Revenue 1,378,779 1,329,942 1,153,195 1,002,232 976,890 977,403 891,166 7.53%
PBT 59,990 99,066 56,818 48,163 53,948 66,103 54,326 1.66%
Tax -24,496 -28,392 -16,215 -15,901 -14,337 -22,616 -19,055 4.27%
NP 35,494 70,674 40,603 32,262 39,611 43,487 35,271 0.10%
-
NP to SH 34,387 69,645 40,215 32,640 38,279 42,242 34,011 0.18%
-
Tax Rate 40.83% 28.66% 28.54% 33.01% 26.58% 34.21% 35.08% -
Total Cost 1,343,285 1,259,268 1,112,592 969,970 937,279 933,916 855,895 7.79%
-
Net Worth 473,857 496,623 464,307 424,715 407,610 374,390 335,831 5.90%
Dividend
30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 CAGR
Div 25,427 29,420 - 50,281 28,885 19,254 16,042 7.97%
Div Payout % 73.95% 42.24% - 154.05% 75.46% 45.58% 47.17% -
Equity
30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 CAGR
Net Worth 473,857 496,623 464,307 424,715 407,610 374,390 335,831 5.90%
NOSH 258,938 117,683 106,983 106,981 106,984 106,968 106,952 15.86%
Ratio Analysis
30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 CAGR
NP Margin 2.57% 5.31% 3.52% 3.22% 4.05% 4.45% 3.96% -
ROE 7.26% 14.02% 8.66% 7.69% 9.39% 11.28% 10.13% -
Per Share
30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 CAGR
RPS 532.47 1,130.10 1,077.92 936.83 913.11 913.73 833.23 -7.18%
EPS 13.28 59.18 37.59 30.51 35.78 39.49 31.80 -13.53%
DPS 9.82 25.00 0.00 47.00 27.00 18.00 15.00 -6.81%
NAPS 1.83 4.22 4.34 3.97 3.81 3.50 3.14 -8.59%
Adjusted Per Share Value based on latest NOSH - 106,924
30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 CAGR
RPS 95.67 92.28 80.01 69.54 67.78 67.82 61.83 7.53%
EPS 2.39 4.83 2.79 2.26 2.66 2.93 2.36 0.21%
DPS 1.76 2.04 0.00 3.49 2.00 1.34 1.11 7.97%
NAPS 0.3288 0.3446 0.3222 0.2947 0.2828 0.2598 0.233 5.90%
Price Multiplier on Financial Quarter End Date
30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 CAGR
Date 30/09/13 28/09/12 30/09/11 30/09/10 30/09/09 30/09/08 28/09/07 -
Price 4.82 7.55 5.90 4.98 4.09 3.24 3.27 -
P/RPS 0.91 0.67 0.55 0.53 0.45 0.35 0.39 15.15%
P/EPS 36.30 12.76 15.70 16.32 11.43 8.20 10.28 23.37%
EY 2.76 7.84 6.37 6.13 8.75 12.19 9.72 -18.91%
DY 2.04 3.31 0.00 9.44 6.60 5.56 4.59 -12.63%
P/NAPS 2.63 1.79 1.36 1.25 1.07 0.93 1.04 16.70%
Price Multiplier on Announcement Date
30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 CAGR
Date 19/11/13 06/11/12 01/11/11 04/11/10 13/11/09 24/11/08 22/11/07 -
Price 4.72 8.25 5.90 4.92 3.93 3.35 3.42 -
P/RPS 0.89 0.73 0.55 0.53 0.43 0.37 0.41 13.77%
P/EPS 35.54 13.94 15.70 16.13 10.98 8.48 10.75 22.03%
EY 2.81 7.17 6.37 6.20 9.10 11.79 9.30 -18.06%
DY 2.08 3.03 0.00 9.55 6.87 5.37 4.39 -11.69%
P/NAPS 2.58 1.95 1.36 1.24 1.03 0.96 1.09 15.42%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment